Exscientia Bags Roche As AI Partner And $26m Series B To Fund Own Pipeline
Exscientia's top executives tell Scrip why Roche opted for its AI insights - and how the UK group will use a $26m series B financing to build its proprietary pipeline.
Exscientia's top executives tell Scrip why Roche opted for its AI insights - and how the UK group will use a $26m series B financing to build its proprietary pipeline.